Revelation Biosciences Inc.
13F holders, Q4 2025 (December 31)13holders +3
8new positions
5sold out
1famous investor
$0.80avg. 13F price*
At the end of Q4 2025, 13 institutions reported holding Revelation Biosciences Inc. in their 13F filings, up 3 from Q3 2025. 8 opened new positions and 5 sold out. The largest holders were Sabby Management, LLC ($484K), Armistice Capital, LLC ($347K) and Citadel Advisors ($44K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Revelation Biosciences Inc.
- CUSIP
- 76135L705
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $152K |
| Exits | 5 | $132K |
All 13F filers, Q3 2025 → Q4 2025: 943,516 shares bought and 93,029 shares sold, net +850,487 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 13 holders
| Sabby Management, LLC | 4.06% | Add +192.5% | 605,702 | $484K |
| Armistice Capital, LLC | 0.01% | Add +442.8% | 434,272 | $347K |
| Citadel Advisors | 0.00% | New | 54,728 | $44K |
| Vanguard Group Inc. | 0.00% | New | 52,505 | $42K |
| Geode Capital Management, LLC | 0.00% | New | 34,019 | $27K |
| Northern Trust Corp. | 0.00% | New | 21,907 | $18K |
| HRT Financial LP | 0.00% | New | 15,320 | $12K |
| XTX Topco Ltd | 0.00% | New | 11,319 | $9K |
| UBS Group AG | 0.00% | Add +36100.0% | 724 | $579 |
| Bank of America Corp. | 0.00% | Add +235.7% | 47 | $38 |
| Danske Bank A/S | 0.00% | No change | 1 | $1 |
| Royal Bank of Canada | 0.00% | New | 2 | $0 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.00% | New | 38 | $0 |
"% of holder's portfolio" is REVELATION BIOSCIENCES INC's weight in each manager's 13F, not the share of Revelation Biosciences Inc. the manager owns.